IBUPROFEN LYSINE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IBUPROFEN LYSINE, covering 2016-03-30 to 2024-07-03. Get the full timeline:
Most recent: FDA Approved: IBUPROFEN LYSINE — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)